Head-to-Head

Atea Pharmaceuticals, Inc. Common Stock vs. Johnson & Johnson

AVIR

Atea Pharmaceuticals, Inc. Common Stock

$5.12 -1.73%

VS JNJ

Johnson & Johnson

$256.03 -1.02%

Johnson & Johnson (JNJ) comes out ahead, leading on 4 of 6 compared factors.

Size & Scale

AVIRJNJ
Market Cap $417.87 million $617.01 billion
Revenue (TTM) — $97.93 billion
Net Income (TTM) $-165,289,000 $21.04 billion

JNJ leads on 3 of 3 size & scale factors.

Valuation

AVIRJNJ
P/E Ratio — 29.70
Price / Book 2.05 7.26
Price / Sales — 6.30

AVIR leads on 1 of 1 valuation factors.

Profitability

AVIRJNJ
Net Margin — 21.48%
Return on Equity -80.96% 24.76%

JNJ leads on 1 of 1 profitability factors.

Dividend

AVIRJNJ
Dividend Yield — 2.09%
Payout Ratio — 62.18

AVIR and JNJ split the dividend factors evenly.

Risk & Sentiment

AVIRJNJ
Short Interest 0.39% 0.67%

AVIR leads on 1 of 1 risk & sentiment factors.

Dig deeper: AVIR overview, AVIR financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.